BlackRock Inc. - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 233 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$28,681,313
-57.7%
8,435,680
-8.6%
0.00%
-50.0%
Q2 2023$67,853,201
-29.3%
9,231,728
-0.3%
0.00%
-33.3%
Q1 2023$95,916,848
-9.3%
9,258,383
+3.4%
0.00%0.0%
Q4 2022$105,761,124
-40.0%
8,955,218
+6.7%
0.00%
-50.0%
Q3 2022$176,191,000
-33.5%
8,394,002
-1.6%
0.01%
-25.0%
Q2 2022$264,862,000
-26.1%
8,532,837
-2.3%
0.01%
-20.0%
Q1 2022$358,533,000
+2.1%
8,731,904
+8.1%
0.01%
+11.1%
Q4 2021$351,104,000
+20.3%
8,076,901
+38.6%
0.01%
+12.5%
Q3 2021$291,788,000
-20.7%
5,827,605
-0.2%
0.01%
-20.0%
Q2 2021$367,785,000
-29.4%
5,838,790
+4.1%
0.01%
-33.3%
Q1 2021$521,084,000
+10.2%
5,608,476
+6.3%
0.02%0.0%
Q4 2020$472,815,000
-10.4%
5,276,948
+3.3%
0.02%
-21.1%
Q3 2020$527,853,000
-2.8%
5,108,399
-25.6%
0.02%
-13.6%
Q2 2020$543,014,000
+41.2%
6,866,640
+3.3%
0.02%
+15.8%
Q1 2020$384,659,000
+4.5%
6,648,077
-2.5%
0.02%
+35.7%
Q4 2019$367,954,000
+5.1%
6,820,268
+1.8%
0.01%
-6.7%
Q3 2019$350,093,000
+5.2%
6,696,522
-2.8%
0.02%
+7.1%
Q2 2019$332,936,000
-2.2%
6,891,631
+2.3%
0.01%
-6.7%
Q1 2019$340,330,000
-12.5%
6,736,576
+2.7%
0.02%
-25.0%
Q4 2018$388,890,000
-7.0%
6,560,237
+3.3%
0.02%
+11.1%
Q3 2018$418,078,000
+54.1%
6,350,905
+18.2%
0.02%
+50.0%
Q2 2018$271,268,000
+15.2%
5,372,711
+20.2%
0.01%
+9.1%
Q1 2018$235,390,000
+12.1%
4,470,829
-1.0%
0.01%
+10.0%
Q4 2017$209,947,000
+17.3%
4,517,898
+2.1%
0.01%
+11.1%
Q3 2017$178,971,000
+21.3%
4,424,549
+1.7%
0.01%
+12.5%
Q2 2017$147,577,000
+21.0%
4,351,987
+3.6%
0.01%
+14.3%
Q1 2017$122,006,000
+121906.0%
4,201,251
+137736.3%
0.01%
Q4 2016$100,000
+7.5%
3,048
+2.6%
0.00%
Q3 2016$93,000
-63.2%
2,971
-67.0%
0.00%
Q2 2016$253,000
+163.5%
8,997
+240.2%
0.00%
Q1 2016$96,000
+60.0%
2,645
+77.0%
0.00%
Q4 2015$60,000
+172.7%
1,494
+92.5%
0.00%
Q3 2015$22,000
-15.4%
7760.0%0.00%
Q2 2015$26,000
+8.3%
776
-6.1%
0.00%
Q1 2015$24,000
+9.1%
8260.0%0.00%
Q4 2014$22,000
+29.4%
8260.0%0.00%
Q3 2014$17,000
-5.6%
8260.0%0.00%
Q2 2014$18,000
-18.2%
826
-6.5%
0.00%
Q1 2014$22,000
+4.8%
8830.0%0.00%
Q4 2013$21,000
+23.5%
8830.0%0.00%
Q3 2013$17,000
+30.8%
8830.0%0.00%
Q2 2013$13,0008830.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Laurus Investment Counsel Inc. 120,504$10,797,0004.20%
SNYDER CAPITAL MANAGEMENT L P 723,477$64,824,0002.12%
Hillcrest Asset Management LLC 161,428$14,464,0001.97%
RICE HALL JAMES & ASSOCIATES, LLC 587,727$52,660,0001.85%
PALISADE CAPITAL MANAGEMENT, LP 579,009$51,879,0001.33%
Pier Capital, LLC 109,786$9,837,0001.04%
Paradiem, LLC 21,320$2,286,0000.97%
EARNEST PARTNERS LLC 1,390,735$124,610,0000.86%
Ridgewood Investments LLC 10,004$1,034,0000.82%
Tygh Capital Management, Inc. 56,334$5,048,0000.78%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders